Literature DB >> 7525732

Spread of hepatitis C virus among sexual partners of HCVAb positive intravenous drug users.

C Gabrielli1, A Zannini, R Corradini, S Gafa.   

Abstract

Recent studies suggest that the seroprevalence of hepatitis C virus antibodies (HCVAb) among sexual partners of those who are HCVAb positive is higher than in the general population. Moreover some studies seem to indicate that transmission of hepatitis C virus (HCV) occurs more readily when there is HIV infection in the couple. We studied the prevalence of HCVAb seropositivity among the regular sexual partners of 84 HCVAb positive intravenous drug users (IVDUs), by means of ELISA confirmed by radio immuno-adsorbent assay, 11 generation (RIBA II). The couples were subdivided into three groups: group 1: 30 HIV negative IVDUs and their HIV negative partners (HIV-/HIV-); group 2: 47 HIV positive IVDUs and their HIV negative partners (HIV+/HIV-); group 3: seven HIV positive IVDUs and their HIV positive partners (HIV+/HIV+). The seroprevalence of HCVAb among the partners of IVDUs was 28.6% in the couples of group 3, 12.8% in the couples of group 2 and no partner was positive among the couples of group 1. There was no statistically significant difference in HCV transmission between the couples who never used a condom and those who always used one. The couples of group 1 never used a condom. We found HCVAb seropositivity only in the partners who were in couples in whom HIV was present. We did not demonstrate that sexual intercourse is a means of HCV transmission because none of the HIV-/HIV- couples of group 1 used a condom and no partner was HCVAb positive.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7525732     DOI: 10.1016/s0163-4453(94)94952-2

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  7 in total

1.  Clinical guidelines on the management of hepatitis C.

Authors:  J C Booth; J O'Grady; J Neuberger
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

2.  Risk factors for hepatitis C virus infection among homeless adults.

Authors:  Adeline M Nyamathi; Elizabeth L Dixon; Wendie Robbins; Cynthia Smith; Dorothy Wiley; Barbara Leake; Douglas Longshore; Lillian Gelberg
Journal:  J Gen Intern Med       Date:  2002-02       Impact factor: 5.128

3.  The management of chronic hepatitis C virus infection.

Authors:  J C Booth; J L Brown; H C Thomas
Journal:  Gut       Date:  1995-10       Impact factor: 23.059

Review 4.  Sexual transmission of hepatitis C virus infection.

Authors:  G Rooney; R J Gilson
Journal:  Sex Transm Infect       Date:  1998-12       Impact factor: 3.519

5.  Prevalence of antibodies to hepatitis C virus in apparently healthy Port Harcourt blood donors and association with blood groups and other risk indicators.

Authors:  Zaccheaus Awortu Jeremiah; Baribefe Koate; Fiekumo Buseri; Felix Emelike
Journal:  Blood Transfus       Date:  2008-07       Impact factor: 3.443

Review 6.  Critical issues in the treatment of hepatitis C virus infection in methadone maintenance patients.

Authors:  David M Novick; Mary Jeanne Kreek
Journal:  Addiction       Date:  2008-04-16       Impact factor: 6.526

Review 7.  Molecular and contextual markers of hepatitis C virus and drug abuse.

Authors:  Paul Shapshak; Charurut Somboonwit; Lydia N Drumright; Simon D W Frost; Deborah Commins; Timothy L Tellinghuisen; William K Scott; Robert Duncan; Clyde McCoy; J Bryan Page; Brian Giunta; Francisco Fernandez; Elyse Singer; Andrew Levine; Alireza Minagar; Oluwadayo Oluwadara; Taiwo Kotila; Francesco Chiappelli; John T Sinnott
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.